Dec 05, 2018 (Heraldkeeper via COMTEX) — New York, December 05, 2018: The Global Spine Biologics Market is expected to exceed more than US$ 2.5 Billion by 2022, at a CAGR of 4.4% in the given forecast period.
The report covers detailed competitive outlook including the market share and company profiles of the key participants operating in the global market. Key players profiled in the report include DePuy Spine, Precision Spine, Medtronic, Stryker Corporation, Smith & Nephew Plc, Orthovita Inc., Zimmer Spine Inc., K2M, Nuvasive, Arthrex, Inc., DMP Spine, Alphatec Spine, Orthofix Holdings, RTI Surgical, Wright Medical Technology, Cesca Therapeutics, and Lattice Biologics. Company profile includes assign such as company summary, financial summary, business strategy and planning, SWOT analysis and current developments.
You Can Browse Full Research Report: https://www.marketresearchengine.com/spine-biologics-market
The Global Spine Biologics Market has been segmented as below:
The Global Spine Biologics Market is Segmented on the lines of By Product Analysis, By Surgery Analysis and By Regional Analysis. By Product Analysis this market is segmented on the basis of Bone graft substitutes, Platelet rich plasma (PRP), Bone grafts and Bone marrow aspirates concentrate (BMAC) therapy.
By Surgery Analysis this market is segmented on the basis of Anterior cervical discectomy and fusion (ACDF), Anterior lumbar interbody fusion (ALIF), Transforaminal lumbar interbody fusion (TLIF), Lateral lumbar interbody fusion (LLIF) and Other surgeries. By Regional Analysis this market is segmented on the basis of North America, Europe, Asia-Pacific and Rest of the World.
A biologic is a material which energetically alters its surrounding atmosphere and effects a change during a biological process. Spine biologics are used through spine fusion surgical procedure for the treatment of spinal defect includes wound, degenerative disc disease, tumors, and spinal cord injuries and wounds by stimulating bone expansion formation through inflammatory repair stage, stage and remodeling stage. Therefore flow in the quantity of spinal fusion surgeries has fueled the acceptance of biologics.
The scope of the report includes a detailed study of global and regional markets for Global Spine Biologics Market with the reasons given for variations in the growth of the industry in certain regions.
Reasons to Buy this Report:
1) Obtain the most up to date information available on all Global Spine Biologics Market.
2) Identify growth segments and opportunities in the industry.
3) Facilitate decision making on the basis of strong historic and forecast of Global Spine Biologics Market data.
4) Assess your competitor’s refining portfolio and its evolution.
The major driving factors of Global Spine Biologics Market are as follows:
- Innovative technological advancements
- Advantages of biologics include faster recovery, minimal postoperative time and ability to activate cellular expansion.
- Demand of minimally invasive spine surgeries is growing
- Increasing ageing population
- Incidences of spinal disorders are raising
- Newly developed spine treatment techniques and devices
The restraining factors of Global Spine Biologics Market are as follows:
- Unfavorable reimbursement policy
- High cost of bone grafts
- Ethical issues associated to bone grafting procedures
- Lack of professional expertise
- Lack of patient awareness and knowledge
Request Sample Report from here: https://www.marketresearchengine.com/spine-biologics-market
Table of Contents
2 Research Methodology
3 Executive Summary
4 Market Overview
5 Spine Biologics Market, By Surgery Type
5.2 Anterior Cervical Discectomy and Fusion (ACDF)
5.3 Posterior Lumbar Interbody Fusion (PLIF)
5.4 Transforaminal Lumbar Interbody Fusion (TLIF)
5.5 Anterior Lumbar Interbody Fusion (ALIF)
5.6 Lateral Lumbar Interbody Fusion (LLIF)
6 Spine Biologics Market By Product Type
7 Spine Biologics Market, By Geography
8 Competitive Landscape
9 Company Profiles
9.1 Zimmer Holding, Inc.
9.2 Depuy Synthes
9.3 Medtronic, Inc. (U.S.)
9.4 Nuvasive, Inc.
9.5 Stryker Corporation
9.6 Orthofix International N.V.
9.7 K2M, Inc.
9.8 Exactech, Inc.
9.9 Wright Medical Technology, Inc.
9.11 Arthrex, Inc.
9.12 X-Spine Systems, Inc. (Bacterin International Holdings, Inc.)
9.13 DR PRP USA LLC
Other Related Market Research Reports:
Company Name: Market Research Engine
Contact Person: John Bay
Country: United States
The post Spine Biologics Market Share will Increase US$ 2.5 Billion by 2022 appeared first on Herald Keeper.
The MarketWatch News Department was not involved in the creation of the content.